S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A. – Trademark Portfolio
Entity Type: 09
S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 17 (Rubber Goods) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SIFLEX, MAGIFLEX, and SIFLEX PACK.
Via Caboto N. 19/8
I- Trieste (TS)
Showing of trademarks Trademarks
Trademark Classifications
S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A. have?
S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A. file in?
S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 17 (Rubber Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A.'s most well-known trademarks?
S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A.'s registered trademark portfolio includes well-known marks such as SIFLEX, MAGIFLEX, and SIFLEX PACK. These are among 3 currently registered trademarks in the portfolio.
What is S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A.'s trademark registration success rate?
S.I.F.RA. EST - SOCIETA' ITALIANA FARMACEUTICI RAVIZZA-EST S.P.A. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.